224 related articles for article (PubMed ID: 37257709)
1. Xihuang pill in the treatment of cancer: TCM theories, pharmacological activities, chemical compounds and clinical applications.
Xu HB; Chen XZ; Wang X; Pan J; Yi-Zhuo Z; Zhou CH
J Ethnopharmacol; 2023 Nov; 316():116699. PubMed ID: 37257709
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of Xihuang Pill/capsule in adjuvant treatment of breast cancer: A systematic review and meta-analysis of 26 randomized controlled trials.
Ge A; Yang K; Deng X; Zhao D; Ge J; Liu L
J Ethnopharmacol; 2022 Sep; 295():115357. PubMed ID: 35545184
[TBL] [Abstract][Full Text] [Related]
3. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
[TBL] [Abstract][Full Text] [Related]
4. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
[TBL] [Abstract][Full Text] [Related]
5. Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions.
Li D; Fan H; Dong J; Sun C; Su Y; Liu J; Gu Y
Breast Cancer (Dove Med Press); 2021; 13():725-742. PubMed ID: 34992452
[TBL] [Abstract][Full Text] [Related]
6. The prospect of
Chen Z; Li Z; Yang S; Wei Y; An J
Heliyon; 2023 Apr; 9(4):e15490. PubMed ID: 37128341
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of Xihuang pills' intervention in the tumour immune microenvironment for the treatment of liver cancer based on the STAT3-PDL1 pathway.
Wang Y; Wang W; Liu K; Liu Y; Shen X; Li Q; Deng F; Hao X; Wang Y
J Ethnopharmacol; 2024 Sep; 331():118278. PubMed ID: 38710457
[TBL] [Abstract][Full Text] [Related]
8. Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells.
Zhang YZ; Yang JY; Wu RX; Fang C; Lu H; Li HC; Li DM; Zuo HL; Ren LP; Liu XY; Xu R; Wen JH; Huang HD; Hong R; Chen QJ
Front Pharmacol; 2021; 12():714628. PubMed ID: 34737698
[TBL] [Abstract][Full Text] [Related]
9. [Effect of serum containing Xihuang pill on proliferation of human breast cancer cell line MDA-MB-435 and MCF-7 Cells].
He LJ; Li JS; Chen X; Zhang HT; Zhu XG; Zhang XD; Xie SH; Gu HO
Zhongguo Zhong Yao Za Zhi; 2018 Jul; 43(13):2784-2788. PubMed ID: 30111032
[TBL] [Abstract][Full Text] [Related]
10. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Xihuang pill for lung cancer: A protocol for systematic review and meta-analysis.
Wang J; Hou D; Peng Y; Xiong J; Xiong L
Medicine (Baltimore); 2020 Oct; 99(41):e22516. PubMed ID: 33031291
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer.
Zhao X; Hao J; Chen S
Evid Based Complement Alternat Med; 2020; 2020():6076572. PubMed ID: 32256653
[TBL] [Abstract][Full Text] [Related]
13. Xihuang Pill enhances anticancer effect of anlotinib by regulating gut microbiota composition and tumor angiogenesis pathway.
Cao B; Wang S; Li R; Wang Z; Li T; Zhang Y; Dong B; Li Y; Lin M; Li X; Xiao X; Li C; Li G
Biomed Pharmacother; 2022 Jul; 151():113081. PubMed ID: 35605293
[TBL] [Abstract][Full Text] [Related]
14. The chemistry and pharmacology of Ligularia przewalskii: A review.
Liu SJ; Tang ZS; Liao ZX; Cui CL; Liu HB; Liang YN; Zhang Y; Xu HB; Zhang DB; Zheng YT; Shi HX; Li SY
J Ethnopharmacol; 2018 Jun; 219():32-49. PubMed ID: 29526703
[TBL] [Abstract][Full Text] [Related]
15. The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms.
Lü S; Wang Q; Li G; Sun S; Guo Y; Kuang H
J Ethnopharmacol; 2015 Dec; 176():177-206. PubMed ID: 26471289
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review.
Wu S; Sun Z; Guo Z; Li P; Mao Q; Tang Y; Chen H; Peng H; Wang S; Cao Y
J Ethnopharmacol; 2023 Oct; 314():116565. PubMed ID: 37172918
[TBL] [Abstract][Full Text] [Related]
17. Bidirectional effects and mechanisms of traditional Chinese medicine.
Peng X; Tang F; Yang Y; Li T; Hu X; Li S; Wu W; He K
J Ethnopharmacol; 2022 Nov; 298():115578. PubMed ID: 35917892
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for the clinical application of the
Tang H; Lu Q; Feng S; Xiao Z; Wu W; Chen G; Deng L; Yu T; Wu J; Lin H; Ji B; Lin J; Zhang C; Li L; Liu T; Ouyang Y; Lei K; Chen J; Peng W; Qiu Z; Cai Q; Liang Q; Liu C; Li Y; Zhu L; Zhang Z; Liu X; Lin L; Zheng Z
Pharm Biol; 2024 Dec; 62(1):472-479. PubMed ID: 38769628
[TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review.
Wei Z; Chen J; Zuo F; Guo J; Sun X; Liu D; Liu C
J Ethnopharmacol; 2023 Jan; 300():115748. PubMed ID: 36162545
[TBL] [Abstract][Full Text] [Related]
20. Modulatory effects of Xihuang Pill on lung cancer treatment by an integrative approach.
Li C; Chen W; Zhang M; Zhang C; Cao B; Dong B; Qi S; Zhang Y; Fei X; Li X; Li R; Wang J; Li G
Biomed Pharmacother; 2020 Oct; 130():110533. PubMed ID: 32739739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
